METHODS AND REAGENTS FOR DIAGNOSIS OF SARS-COV-2 INFECTION
The present invention relates to a method for diagnosing a SARS-CoV-2 infection comprising the step of detecting the presence or absence of an antibody to SEQ ID NO: 1, preferably IgA class antibody, in a sample from a subject, a method for the differential diagnosis of a coronavirus infection, a us...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Lindhorst, Fabian Stiba, Konstanze Müller, Marcel Corman, Victor Lattwein, Erik Steinhagen, Katja Messing, Claudia Neugebauer, Eva |
| description | The present invention relates to a method for diagnosing a SARS-CoV-2 infection comprising the step of detecting the presence or absence of an antibody to SEQ ID NO: 1, preferably IgA class antibody, in a sample from a subject, a method for the differential diagnosis of a coronavirus infection, a use of an antibody to SEQ ID NO: 1, preferably IgA class antibody for diagnosing a SARS-CoV-2 infection or for the differential diagnosis of a coronavirus infection, preferably for distinguishing between a SARS-CoV-2, MERS and NL63, 229E, OC43 and HKU1 infection, and a kit comprising a polypeptide comprising SEQ ID NO: 1 or a variant thereof, preferably coated to a diagnostically useful carrier and one or more, preferably all reagents from the group comprising an antibody to SEQ ID NO: 1, a washing buffer, a means for detecting the presence of an antibody, preferably IgA class antibody, preferably a secondary antibody binding specifically to IgA class antibodies, preferably comprising a detectable label, and a dilution buffer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3978927A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3978927A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3978927A23</originalsourceid><addsrcrecordid>eNrjZLDydQ3x8HcJVnD0c1EIcnV0d_ULCVZw8w9ScPF0dPfzD_YMVvB3Uwh2DArWdfYP0zVS8PRzc3UO8fT342FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxpbmFpZG5o5GxkQoAQBC-yhu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS AND REAGENTS FOR DIAGNOSIS OF SARS-COV-2 INFECTION</title><source>esp@cenet</source><creator>Lindhorst, Fabian ; Stiba, Konstanze ; Müller, Marcel ; Corman, Victor ; Lattwein, Erik ; Steinhagen, Katja ; Messing, Claudia ; Neugebauer, Eva</creator><creatorcontrib>Lindhorst, Fabian ; Stiba, Konstanze ; Müller, Marcel ; Corman, Victor ; Lattwein, Erik ; Steinhagen, Katja ; Messing, Claudia ; Neugebauer, Eva</creatorcontrib><description>The present invention relates to a method for diagnosing a SARS-CoV-2 infection comprising the step of detecting the presence or absence of an antibody to SEQ ID NO: 1, preferably IgA class antibody, in a sample from a subject, a method for the differential diagnosis of a coronavirus infection, a use of an antibody to SEQ ID NO: 1, preferably IgA class antibody for diagnosing a SARS-CoV-2 infection or for the differential diagnosis of a coronavirus infection, preferably for distinguishing between a SARS-CoV-2, MERS and NL63, 229E, OC43 and HKU1 infection, and a kit comprising a polypeptide comprising SEQ ID NO: 1 or a variant thereof, preferably coated to a diagnostically useful carrier and one or more, preferably all reagents from the group comprising an antibody to SEQ ID NO: 1, a washing buffer, a means for detecting the presence of an antibody, preferably IgA class antibody, preferably a secondary antibody binding specifically to IgA class antibodies, preferably comprising a detectable label, and a dilution buffer.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; TESTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220406&DB=EPODOC&CC=EP&NR=3978927A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25573,76557</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220406&DB=EPODOC&CC=EP&NR=3978927A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Lindhorst, Fabian</creatorcontrib><creatorcontrib>Stiba, Konstanze</creatorcontrib><creatorcontrib>Müller, Marcel</creatorcontrib><creatorcontrib>Corman, Victor</creatorcontrib><creatorcontrib>Lattwein, Erik</creatorcontrib><creatorcontrib>Steinhagen, Katja</creatorcontrib><creatorcontrib>Messing, Claudia</creatorcontrib><creatorcontrib>Neugebauer, Eva</creatorcontrib><title>METHODS AND REAGENTS FOR DIAGNOSIS OF SARS-COV-2 INFECTION</title><description>The present invention relates to a method for diagnosing a SARS-CoV-2 infection comprising the step of detecting the presence or absence of an antibody to SEQ ID NO: 1, preferably IgA class antibody, in a sample from a subject, a method for the differential diagnosis of a coronavirus infection, a use of an antibody to SEQ ID NO: 1, preferably IgA class antibody for diagnosing a SARS-CoV-2 infection or for the differential diagnosis of a coronavirus infection, preferably for distinguishing between a SARS-CoV-2, MERS and NL63, 229E, OC43 and HKU1 infection, and a kit comprising a polypeptide comprising SEQ ID NO: 1 or a variant thereof, preferably coated to a diagnostically useful carrier and one or more, preferably all reagents from the group comprising an antibody to SEQ ID NO: 1, a washing buffer, a means for detecting the presence of an antibody, preferably IgA class antibody, preferably a secondary antibody binding specifically to IgA class antibodies, preferably comprising a detectable label, and a dilution buffer.</description><subject>CHEMISTRY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDydQ3x8HcJVnD0c1EIcnV0d_ULCVZw8w9ScPF0dPfzD_YMVvB3Uwh2DArWdfYP0zVS8PRzc3UO8fT342FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxpbmFpZG5o5GxkQoAQBC-yhu</recordid><startdate>20220406</startdate><enddate>20220406</enddate><creator>Lindhorst, Fabian</creator><creator>Stiba, Konstanze</creator><creator>Müller, Marcel</creator><creator>Corman, Victor</creator><creator>Lattwein, Erik</creator><creator>Steinhagen, Katja</creator><creator>Messing, Claudia</creator><creator>Neugebauer, Eva</creator><scope>EVB</scope></search><sort><creationdate>20220406</creationdate><title>METHODS AND REAGENTS FOR DIAGNOSIS OF SARS-COV-2 INFECTION</title><author>Lindhorst, Fabian ; Stiba, Konstanze ; Müller, Marcel ; Corman, Victor ; Lattwein, Erik ; Steinhagen, Katja ; Messing, Claudia ; Neugebauer, Eva</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3978927A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>Lindhorst, Fabian</creatorcontrib><creatorcontrib>Stiba, Konstanze</creatorcontrib><creatorcontrib>Müller, Marcel</creatorcontrib><creatorcontrib>Corman, Victor</creatorcontrib><creatorcontrib>Lattwein, Erik</creatorcontrib><creatorcontrib>Steinhagen, Katja</creatorcontrib><creatorcontrib>Messing, Claudia</creatorcontrib><creatorcontrib>Neugebauer, Eva</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Lindhorst, Fabian</au><au>Stiba, Konstanze</au><au>Müller, Marcel</au><au>Corman, Victor</au><au>Lattwein, Erik</au><au>Steinhagen, Katja</au><au>Messing, Claudia</au><au>Neugebauer, Eva</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS AND REAGENTS FOR DIAGNOSIS OF SARS-COV-2 INFECTION</title><date>2022-04-06</date><risdate>2022</risdate><abstract>The present invention relates to a method for diagnosing a SARS-CoV-2 infection comprising the step of detecting the presence or absence of an antibody to SEQ ID NO: 1, preferably IgA class antibody, in a sample from a subject, a method for the differential diagnosis of a coronavirus infection, a use of an antibody to SEQ ID NO: 1, preferably IgA class antibody for diagnosing a SARS-CoV-2 infection or for the differential diagnosis of a coronavirus infection, preferably for distinguishing between a SARS-CoV-2, MERS and NL63, 229E, OC43 and HKU1 infection, and a kit comprising a polypeptide comprising SEQ ID NO: 1 or a variant thereof, preferably coated to a diagnostically useful carrier and one or more, preferably all reagents from the group comprising an antibody to SEQ ID NO: 1, a washing buffer, a means for detecting the presence of an antibody, preferably IgA class antibody, preferably a secondary antibody binding specifically to IgA class antibodies, preferably comprising a detectable label, and a dilution buffer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3978927A2 |
| source | esp@cenet |
| subjects | CHEMISTRY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS TESTING |
| title | METHODS AND REAGENTS FOR DIAGNOSIS OF SARS-COV-2 INFECTION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-29T19%3A33%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Lindhorst,%20Fabian&rft.date=2022-04-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3978927A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |